The National Asthma Council Logo

 

 

Leading the attack against asthma

Search website
Home About the NAC Strategy Managing Asthma Research Emergency
 
Inhaled Corticosteroids:

A Practical Perspective

 
Asthma Management Handbook Asthma Action Plans Spirometry Resources  Other Resources Information Papers Special Topics Professional Development  

Long-Acting Beta2 Agonists: Their Place in Asthma Management

Home
What are Long-acting Beta2 Agonists
Clinical Use of Symptom Controllers
Recent Studies Characterising the Role of Beta2 Agonists
Dosage and Administration of Symptom Controllers
Content created Aug 1998
Page updated 31 Aug 2005

Get Acrobat Viewer

Welcome

Long-Acting Beta2 Agonists or 'Symptom Controllers'

Their Place in Asthma Management

This brochure has been written for practising clinicians to assist in appreciating the role of long-acting beta2 agonists. It is not a comprehensive treatise and approved product information should be utilised for full information.

The National Asthma Council will provide a referenced information sheet on the pharmacological profiles of long-acting beta2 agonists on application to the following toll-free number: 1800 032 495

 

Content created: August 1998

 

Contents

What are Long-acting Beta2 Agonists or Symptom Controllers?

Clinical Use of Symptom Controllers

Recent Studies Characterising the Role of Beta2 Agonists

Dosage and Administration of Symptom Controllers

ForwardBack

 

 

 

 

 

 

 

Long-Acting Beta2 Agonists or 'Symptom Controllers'

Proudly supported by

AstraZeneca

Glaxo SmithKline

Novartis